Prevest Denpro reported a strong fiscal year ended March 31, 2026, with consolidated revenue up 13.9% and PAT growing 12.9%. The company plans to expand into digital dentistry and disinfectants.
Prevest Denpro Ltd. Reports Robust Full Year Financial Performance
Consolidated Revenue: ₹71.81 crore, up 13.9% YoY. Consolidated PAT: ₹20.49 crore, up 12.9% YoY. Reader Takeaway: Steady growth drivers plus future expansion into new dental tech categories. ## What Just Happened Prevest Denpro Limited announced its financial results for the full year ended March 31, 2026. The company reported a 13.9% increase in consolidated revenue to ₹71.81 crore and a 12.9% rise in consolidated profit after tax (PAT) to ₹20.49 crore. Consolidated EBITDA also saw a healthy rise of 13.3% to ₹29.62 crore. On a standalone basis, the company achieved revenue from operations of ₹71.66 crore and a standalone PAT of ₹21.42 crore. Its standalone EBITDA margin stood at a strong 39.8%. ## Why This Matters The consistent double-digit growth in both revenue and profit highlights the company's expanding market reach and operational efficiency. The strong standalone EBITDA margin indicates good cost management and product profitability. This performance provides a solid foundation for the company's future growth plans. ## The Backstory Prevest Denpro operates from a 60,000 sq. ft. manufacturing facility. The company has established a presence in over 90 countries and works with over 145 dealers in India and more than 120 overseas business partners. This widespread network has been key to its consistent performance. ## What Changes Now For the upcoming fiscal year (FY 2027), Prevest Denpro plans to expand into new categories including Digital Dentistry and Disinfectants. It will also focus on strengthening its domestic presence in Tier I and Tier II cities and increasing indigenous sourcing of critical raw materials. The company also aims to integrate advanced technology, including 3D printing ecosystems. ## Risks to Watch While the company's expansion plans are promising, successful execution in new, technologically advanced categories like digital dentistry will be crucial. Dependence on import for critical raw materials, though being addressed through localization efforts, remains a factor for margin stability. ## Peer Comparison Prevest Denpro operates in the dental materials and consumables sector. While specific peer financial comparisons require detailed analysis of listed entities in this niche, the company's reported EBITDA margins suggest competitive operational efficiency within its segment. ## Context Metrics (Time-Bound) Consolidated Revenue FY 2025-2026: ₹71.81 crore (vs ₹63.03 crore in FY 2024-2025). Consolidated EBITDA FY 2025-2026: ₹29.62 crore (vs ₹26.15 crore in FY 2024-2025). Consolidated PAT FY 2025-2026: ₹20.49 crore (vs ₹18.16 crore in FY 2024-2025). Standalone EBITDA Margin FY 2025-2026: 39.8%. ## What to Track Next Investors will be keen to monitor the progress of new product launches in Digital Dentistry and Disinfectants. The company's success in localizing raw material sourcing and its continued expansion in domestic and international markets will also be key factors to watch.
